[
  {
    "ts": null,
    "headline": "The GLP-1 Saga Continues, And How",
    "summary": "The GLP-1 Saga Continues, And How",
    "url": "https://finnhub.io/api/news?id=204931e369efb88a8dd36991182948f33ff0cf9af25198dbd417b8f9328e27c1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746133500,
      "headline": "The GLP-1 Saga Continues, And How",
      "id": 134178628,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=204931e369efb88a8dd36991182948f33ff0cf9af25198dbd417b8f9328e27c1"
    }
  },
  {
    "ts": null,
    "headline": "'Declare victory and move on': Eli Lilly CEO on Trump tariff threat",
    "summary": "Eli Lilly CEO says Trump tariff threat has already achieved the goal of repatriating manufacturing in pharma.",
    "url": "https://finnhub.io/api/news?id=2c2e5044bc33af9ac4601d0d887ececd2ba1d64326a151e7e310a973c8dc0dd0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746115606,
      "headline": "'Declare victory and move on': Eli Lilly CEO on Trump tariff threat",
      "id": 134173462,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Eli Lilly CEO says Trump tariff threat has already achieved the goal of repatriating manufacturing in pharma.",
      "url": "https://finnhub.io/api/news?id=2c2e5044bc33af9ac4601d0d887ececd2ba1d64326a151e7e310a973c8dc0dd0"
    }
  },
  {
    "ts": null,
    "headline": "LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down",
    "summary": "Eli Lilly misses first-quarter estimates for earnings but beats the same for sales. Mounjaro and Zepbound sales beat estimates. Stock declines.",
    "url": "https://finnhub.io/api/news?id=4acd05c8007add68ad56a50881f5924d6589d6efe174240f2278163f846946e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746114660,
      "headline": "LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down",
      "id": 134175950,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Eli Lilly misses first-quarter estimates for earnings but beats the same for sales. Mounjaro and Zepbound sales beat estimates. Stock declines.",
      "url": "https://finnhub.io/api/news?id=4acd05c8007add68ad56a50881f5924d6589d6efe174240f2278163f846946e2"
    }
  },
  {
    "ts": null,
    "headline": "Arvinas Shares Drop; Cancels Two Drug Trials With Pfizer Amid Capital Markets Challenges",
    "summary": "Arvinas Shares Drop; Cancels Two Drug Trials With Pfizer Amid Capital Markets Challenges",
    "url": "https://finnhub.io/api/news?id=818aa25c5941ebbf9df70cf7c12bc29ac1ac628ff632cfceb8868fe21738ebf8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746109560,
      "headline": "Arvinas Shares Drop; Cancels Two Drug Trials With Pfizer Amid Capital Markets Challenges",
      "id": 134190659,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Arvinas Shares Drop; Cancels Two Drug Trials With Pfizer Amid Capital Markets Challenges",
      "url": "https://finnhub.io/api/news?id=818aa25c5941ebbf9df70cf7c12bc29ac1ac628ff632cfceb8868fe21738ebf8"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: Regulatory Hurdles And Market Challenges Prompt Downgrade To Sell",
    "summary": "Moderna faces revenue declines, regulatory setbacks, and market challenges as COVID-19 vaccine demand wanes. Learn more about MRNA stock here.",
    "url": "https://finnhub.io/api/news?id=b99a4fcdda3ba0527d2c2b2dd8c0a4a41c4a47a2d3f4b04d58f47a2e46cb3458",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746106212,
      "headline": "Moderna: Regulatory Hurdles And Market Challenges Prompt Downgrade To Sell",
      "id": 134175280,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1253985645/image_1253985645.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Moderna faces revenue declines, regulatory setbacks, and market challenges as COVID-19 vaccine demand wanes. Learn more about MRNA stock here.",
      "url": "https://finnhub.io/api/news?id=b99a4fcdda3ba0527d2c2b2dd8c0a4a41c4a47a2d3f4b04d58f47a2e46cb3458"
    }
  },
  {
    "ts": null,
    "headline": "Q1 2025 OPKO Health Inc Earnings Call",
    "summary": "Q1 2025 OPKO Health Inc Earnings Call",
    "url": "https://finnhub.io/api/news?id=26ed1777c1fd73054769473f70a2a54e5e394828187e7ca0477080f5866c7746",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746104249,
      "headline": "Q1 2025 OPKO Health Inc Earnings Call",
      "id": 134173655,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Q1 2025 OPKO Health Inc Earnings Call",
      "url": "https://finnhub.io/api/news?id=26ed1777c1fd73054769473f70a2a54e5e394828187e7ca0477080f5866c7746"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance",
    "summary": "Eli Lilly reported first quarter earnings on Thursday.",
    "url": "https://finnhub.io/api/news?id=57777f565dfc2c8fb091134cef17cb16e524506b08a80d3292f275a385ae3d12",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746104088,
      "headline": "Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance",
      "id": 134173471,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Eli Lilly reported first quarter earnings on Thursday.",
      "url": "https://finnhub.io/api/news?id=57777f565dfc2c8fb091134cef17cb16e524506b08a80d3292f275a385ae3d12"
    }
  },
  {
    "ts": null,
    "headline": "Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks",
    "summary": "Top-ranked stocks Fox (FOXA), Universal Technical Institute (UTI), Pfizer (PFE), Tenet Healthcare (THC) and Newmont (NEM) are likely to beat on the bottom line in their upcoming releases.",
    "url": "https://finnhub.io/api/news?id=dc97f5b28c8c7268a3c6d80082534d4d68d937106d457a4cb26e4e1268315c57",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746103200,
      "headline": "Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks",
      "id": 134173657,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Top-ranked stocks Fox (FOXA), Universal Technical Institute (UTI), Pfizer (PFE), Tenet Healthcare (THC) and Newmont (NEM) are likely to beat on the bottom line in their upcoming releases.",
      "url": "https://finnhub.io/api/news?id=dc97f5b28c8c7268a3c6d80082534d4d68d937106d457a4cb26e4e1268315c57"
    }
  },
  {
    "ts": null,
    "headline": "3 Market Predictions For May",
    "summary": "Here is my list of three expert market predictions for May 2025, including insights on yields and job market trends. Read what investors need to know.",
    "url": "https://finnhub.io/api/news?id=eca552d4fb45ce3a72c25754ead9dcdb5e1a002b877d554debd00f34822916cd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746102884,
      "headline": "3 Market Predictions For May",
      "id": 134173206,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1492960748/image_1492960748.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Here is my list of three expert market predictions for May 2025, including insights on yields and job market trends. Read what investors need to know.",
      "url": "https://finnhub.io/api/news?id=eca552d4fb45ce3a72c25754ead9dcdb5e1a002b877d554debd00f34822916cd"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Earnings Beat Expectations. Why the Stock Is Falling.",
    "summary": "Eli Lilly Earnings Beat Expectations. Why the Stock Is Falling.",
    "url": "https://finnhub.io/api/news?id=a6e5ebc06f9c3e91192386c3e82936ec6fa27d0eed4f6d5b5a6652b18fa25ad6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746094020,
      "headline": "Eli Lilly Earnings Beat Expectations. Why the Stock Is Falling.",
      "id": 134179448,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Eli Lilly Earnings Beat Expectations. Why the Stock Is Falling.",
      "url": "https://finnhub.io/api/news?id=a6e5ebc06f9c3e91192386c3e82936ec6fa27d0eed4f6d5b5a6652b18fa25ad6"
    }
  },
  {
    "ts": null,
    "headline": "Zacks.com featured highlights Centene, Pediatrix Medical, Pfizer, StoneCo and Banco Santander",
    "summary": "Centene, Pediatrix Medical, Pfizer, StoneCo and Banco Santander have been highlighted in this Screen of The Week article.",
    "url": "https://finnhub.io/api/news?id=ba438868369d90b0f1ed744b35372b1b95d6e2c95b4e2818785549a50f72e4e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746089400,
      "headline": "Zacks.com featured highlights Centene, Pediatrix Medical, Pfizer, StoneCo and Banco Santander",
      "id": 134173658,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Centene, Pediatrix Medical, Pfizer, StoneCo and Banco Santander have been highlighted in this Screen of The Week article.",
      "url": "https://finnhub.io/api/news?id=ba438868369d90b0f1ed744b35372b1b95d6e2c95b4e2818785549a50f72e4e5"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Harvesting Portfolio Week 217: $21,700 Allocated, $2,179.74 In Projected Dividends",
    "summary": "Alphabet's strong earnings and $75 billion capex reaffirmation set a bullish tone for big tech. Check out my Dividend Harvesting Portfolio this week.",
    "url": "https://finnhub.io/api/news?id=50fa7531b767cf139037d3f081db8e51d04781e2ec408287ce91844d7b61d27e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746089100,
      "headline": "Dividend Harvesting Portfolio Week 217: $21,700 Allocated, $2,179.74 In Projected Dividends",
      "id": 134171579,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445810122/image_1445810122.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Alphabet's strong earnings and $75 billion capex reaffirmation set a bullish tone for big tech. Check out my Dividend Harvesting Portfolio this week.",
      "url": "https://finnhub.io/api/news?id=50fa7531b767cf139037d3f081db8e51d04781e2ec408287ce91844d7b61d27e"
    }
  },
  {
    "ts": null,
    "headline": "Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks.",
    "summary": "There's no need to track down complicated and obscure businesses. Some of the market's best income-producing stocks are hiding in plain sight.",
    "url": "https://finnhub.io/api/news?id=8872a15498991be8389e55a536fc87cb2c6db00986d6f694ca3ef7808c4016aa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746087300,
      "headline": "Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks.",
      "id": 134173659,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "There's no need to track down complicated and obscure businesses. Some of the market's best income-producing stocks are hiding in plain sight.",
      "url": "https://finnhub.io/api/news?id=8872a15498991be8389e55a536fc87cb2c6db00986d6f694ca3ef7808c4016aa"
    }
  },
  {
    "ts": null,
    "headline": "OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ...",
    "summary": "OPKO Health Inc (OPK) navigates a challenging quarter with strategic asset sales, cost-saving measures, and promising developments in its pharmaceutical pipeline.",
    "url": "https://finnhub.io/api/news?id=e567957e9cd83c0c0aed4d32ac0557b1b8448790ffa6c0b1717ca31517f81ad3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746083841,
      "headline": "OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ...",
      "id": 134173660,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "OPKO Health Inc (OPK) navigates a challenging quarter with strategic asset sales, cost-saving measures, and promising developments in its pharmaceutical pipeline.",
      "url": "https://finnhub.io/api/news?id=e567957e9cd83c0c0aed4d32ac0557b1b8448790ffa6c0b1717ca31517f81ad3"
    }
  }
]